Background. Lots of the therapeutic proposals for COVID-19 have already been connected with adverse outcomes, such as the danger of QT interval prolongation and torsades de pointes (TdP). The target was to ascertain the use of medicine that has a chance of QT interval prolongation in 21 clinics/hospitals in https://directivepublications.org/journal-of-vascular-medicine/